From: Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
MMSE score | GroupA(n = 27) Mean ± SD | Group B (n = 26) Mean ± SD | P value |
---|---|---|---|
T1 | 21.59 ± 4.19 | 21.65 ± 4.56 | 0.960 |
T2 | 19.96 ± 4.55 | 19.53 ± 4.36 | 0.730 |
T3 | 24.77 ± 2.76 | 24.84 ± 2.98 | 0.931 |
T4 | 20.37 ± 5.83 | 23.84 ± 4.49 | 0.019 |